Loading people...
Eric Dai is an Investor at Dimension, a venture capital firm where he evaluates early-stage opportunities at the intersection of technology and life sciences. Prior to joining Dimension in September 2023, he served as an Analyst at Andreessen Horowitz within the firm's Bio + Health investment practice. In this capacity, he covered emerging startups across therapeutics, diagnostics, and biological infrastructure, building upon his earlier startup incubation and community-building experience with Petri Bio, the BIOS Community, and Nucleate. Dai holds a Bachelor of Science in Bioengineering from Washington University in St. Louis and is currently on an official leave of absence from his doctoral studies in Bioengineering at the University of Pennsylvania. His professional background bridges academic bioengineering research with venture capital analysis, maintaining a core focus on supporting founders who are advancing modern healthcare technologies.
Eric Dai is a key member of the investment team at Andreessen Horowitz (a16z), one of the most influential venture capital firms in Silicon Valley. As an Analyst, Eric plays a crucial role in the firm's rigorous process of discovering and evaluating the next generation of transformative technology companies. His responsibilities typically involve deep market research, trend analysis, and due diligence to support potential investments across a wide array of sectors.
At Andreessen Horowitz, Eric Dai contributes to the firm's broad investment mandate, which spans enterprise software, fintech, consumer technology, crypto, and artificial intelligence. While specific investment focuses for analysts can vary, Eric's work aligns with a16z's mission to back bold entrepreneurs building the future. He is often involved in identifying nascent market opportunities, understanding competitive landscapes, and assessing the technical and business viability of early-stage startups. This foundational work is critical for the firm's partners in making informed investment decisions.
Eric's career background likely reflects a strong analytical aptitude and a keen interest in technology and innovation, qualities highly valued at Andreessen Horowitz. Individuals in analyst roles at top-tier VC firms often come from diverse backgrounds, including technology, finance, or entrepreneurship, bringing fresh perspectives to investment theses. While specific details of Eric Dai's prior experience are not publicly detailed, his position at a16z suggests a track record of intellectual curiosity and a capacity for rigorous research and strategic thinking.
As an Analyst, Eric's contributions are primarily in supporting the firm's overall investment activities rather than leading specific deals. His work helps to build the pipeline of potential investments and provides critical insights that inform the firm's portfolio strategy. Andreessen Horowitz is known for its extensive network and deep expertise, and Eric Dai's efforts contribute directly to maintaining the firm's position at the forefront of technology investing. He is part of a team dedicated to empowering founders and shaping the future of technology.
Eric Dai is an Analyst at Andreessen Horowitz, a leading venture capital firm. He is involved in researching emerging technologies and market trends to support the firm's investment strategies.
As an Analyst at Andreessen Horowitz, Eric Dai supports investments across various high-growth technology sectors. These typically include enterprise software, fintech, consumer technology, crypto, and artificial intelligence, aligning with a16z's broad investment focus.
Eric Dai works at Andreessen Horowitz (a16z), a prominent venture capital firm based in Silicon Valley, known for its investments in groundbreaking technology companies.
